Suppr超能文献

通过将淋巴瘤突变体与H-2k单倍型的L细胞融合,在MHC I类途径中恢复H-2b表达和内源性抗原的加工处理。

Restoration of H-2b expression and processing of endogenous antigens in the MHC class I pathway by fusion of a lymphoma mutant to L cells of the H-2k haplotype.

作者信息

Ohlén C, Bastin J, Ljunggren H G, Imreh S, Klein G, Townsend A R, Kärre K

机构信息

Department of Tumor Biology, Karolinska Institutet, Stockholm, Sweden.

出版信息

Eur J Immunol. 1990 Aug;20(8):1873-6. doi: 10.1002/eji.1830200837.

Abstract

The RMA-S lymphoma mutant cannot process and present antigens to H-2-restricted cytotoxic T lymphocytes. It synthesizes major histocompatibility complex class I heavy (H-2KbDb) and light beta 2-microglobulin (beta 2mb) chains of normal size and charge, but only a fraction of these assemble and reach the cell surface. As a first step investigating the genetic defect of this line, we have fused it to a L cell fibroblast line (H-2KkDk/beta 2ma). The fusion restored H-2Kb, Db and beta 2mb expression as well as the ability to process and present internally derived (minor histocompatibility and influenza virus nucleoprotein) antigens in RMA-S. This shows that the mutation(s) responsible for the phenotype of RMA-S is (are) not located within the MHC class I heavy and light chain genes. Other cellular factors, derived from the L cell fusion partner, can control antigen processing and transport of MHC class I molecules. These findings are discussed in relation to the observation that assembly and transport of MHC class I molecules can be induced in the mutant by H-2b-restricted peptides. The recessive nature of the defect and its independence of MHC class I genes in the mutant has important implications for future transfection studies, of this and similar mutants, aiming at establishing cells containing non-assembled MHC class I molecules of different alleles and identifying the gene(s) controlling processing of endogenous antigens.

摘要

RMA-S淋巴瘤突变体无法处理抗原并将其呈递给受H-2限制的细胞毒性T淋巴细胞。它能合成正常大小和电荷的主要组织相容性复合体I类重链(H-2KbDb)和轻链β2-微球蛋白(β2mb),但只有一小部分组装并到达细胞表面。作为研究该细胞系遗传缺陷的第一步,我们将其与L细胞成纤维细胞系(H-2KkDk/β2ma)进行了融合。融合恢复了RMA-S中H-2Kb、Db和β2mb的表达,以及处理和呈递内源性(次要组织相容性和流感病毒核蛋白)抗原的能力。这表明导致RMA-S表型的突变不在MHC I类重链和轻链基因内。来自L细胞融合伙伴的其他细胞因子可以控制MHC I类分子的抗原处理和运输。结合H-2b限制肽可在突变体中诱导MHC I类分子组装和运输这一观察结果,对这些发现进行了讨论。该突变体中缺陷的隐性性质及其与MHC I类基因的独立性,对于未来针对该突变体及类似突变体的转染研究具有重要意义,这些研究旨在建立含有不同等位基因未组装MHC I类分子的细胞,并鉴定控制内源性抗原处理的基因。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验